I-Rabeprazole Sodium CAS 117976-90-6 Purity >99.5% (HPLC) API Factory
I-Ruifu Chemical Supply Rabeprazole Sodium Intermediates
I-Rabeprazole Sodium CAS 117976-90-6
I-Rabeprazole Hydroxy Compound CAS 675198-19-3
I-Rabeprazole Chloride Compound CAS 153259-31-5
Igama Lekhemikhali | I-Rabeprazole Sodium |
Omqondofana | I-2-([4-(3-Methoxypropoxy)-3-Methylpyridin-2-yl]methylsulfinyl)-1H-Benzo[d]imidazole;I-Pariprazole |
Inombolo ye-CAS | 117976-90-6 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C18H20N3NaO3S |
Isisindo samangqamuzana | 381.42 |
I-Melting Point | 140.0 ~ 141.0℃ |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Ikristalu Eliphuzi Kancane ukuya Eliphuzi Kancane noma Impushana;I-Hygroscopic |
I-Infrared Spectrum | Ivumelana Nesakhiwo |
I-Proton NMR Spectrum | Ivumelana Nesakhiwo |
I-ICP | Iqinisekisa Ingxenye Yesodium |
Ukuncibilika | Incibilika Ngokuphelele Emanzini;I-Soluble Kakhulu ku-Ethanol, i-Chloroform;I-Soluble ku-Methanol |
pH | 9.5~12.0 |
Ukulahlekelwa Ekumisweni | <1.00% |
Izinsimbi Ezisindayo | <20ppm |
Izinto Ezihlobene | (HPLC) |
Ukungcola A | <0.80% |
Ukungcola Okungashiwongo | <0.20% |
Ukungcola Okuphelele | <1.00% |
Izincibilikisi Ezisele | (GC) |
I-Methylene Chloride | <600ppm |
I-Ethanol | <5000ppm |
I-Isopropyl Ether | <5000ppm |
I-acetone | <5000ppm |
Umkhawulo weMicrobial | |
I-Aerobe Count | ≤1000CFU/g |
Isikhunta Nembiliso Kubalwa | ≤100CFU/g |
E. Coli | Ayikho ngegremu ngayinye |
Ukuhlanzeka / Indlela Yokuhlaziya | >99.5% (HPLC, Isisekelo Esomisiwe) |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-API ye-Anti-Ulcer |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
I-Rabeprazole Sodium (i-CAS: 117976-90-6) iyi-proton pump inhibitor ecindezela ukukhiqizwa kwe-gastric acid esiswini.Inokusetshenziswa okuningana kwezokwelapha: ukulawulwa kwezimo ezibandakanya ukukhiqizwa kwe-asidi esesiswini ngokweqile (isb. I-Zollinger-Ellison syndrome), izimo ezimbi kakhulu ngenxa ye-asidi esiswini (isb. izilonda emgudwini wesisu), nezimo ezibandakanya ukuchayeka isikhathi eside ku-asidi yesisu (isb. isifo se-reflux ye-gastroesophageal).I-Rabeprazole nayo iyasiza kanye nokwelashwa ngama-antibiotic ekwelapheni i-pathogen i-Helicobacter pylori, echumayo endaweni ene-asidi.Ngakho-ke, i-Rabeprazole Sodium iyi-FDA egunyazwe ukwelashwa kwe-GERD enezimpawu entsheni nakubantu abadala, ukuphulukisa izilonda ze-duodenal kubantu abadala, ukuqedwa kwe-Helicobacter pylori, kanye nezimo ze-pathologic hypersecretory.I-Rabeprazole Sodium icindezela ukukhiqizwa kwe-asidi esiswini ngokuvimbela i-H+/K+ATPase yesisu (i-hydrogen-potassium adenosine triphosphatase) endaweni eyimfihlo yeseli ye-gastric parietal.